User profiles for Daniel Wrapp
 | Daniel WrappPostdoctoral Associate, Duke Human Vaccine Institute Verified email at duke.edu Cited by 19064 |
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
The outbreak of a novel coronavirus (2019-nCoV) represents a pandemic threat that has
been declared a public health emergency of international concern. The CoV spike (S) …
been declared a public health emergency of international concern. The CoV spike (S) …
[PDF][PDF] Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies
Coronaviruses make use of a large envelope protein called spike (S) to engage host cell
receptors and catalyze membrane fusion. Because of the vital role that these S proteins play, …
receptors and catalyze membrane fusion. Because of the vital role that these S proteins play, …
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
Middle East respiratory syndrome coronavirus (MERS-CoV) is a lineage C betacoronavirus
that since its emergence in 2012 has caused outbreaks in human populations with case-…
that since its emergence in 2012 has caused outbreaks in human populations with case-…
[HTML][HTML] Immunogenicity of a DNA vaccine candidate for COVID-19
…, M Khoshnejad, N Wang, J Chu, D Wrapp… - Nature …, 2020 - nature.com
The coronavirus family member, SARS-CoV-2 has been identified as the causal agent for
the pandemic viral pneumonia disease, COVID-19. At this time, no vaccine is available to …
the pandemic viral pneumonia disease, COVID-19. At this time, no vaccine is available to …
[HTML][HTML] SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
…, A West, KL Gully, LJ Stevens, N Wang, D Wrapp… - Nature, 2020 - nature.com
A vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed to
control the coronavirus disease 2019 (COVID-19) global pandemic. Structural studies have …
control the coronavirus disease 2019 (COVID-19) global pandemic. Structural studies have …
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
The coronavirus disease 2019 (COVID-19) pandemic has led to accelerated efforts to develop
therapeutics and vaccines. A key target of these efforts is the spike (S) protein, which is …
therapeutics and vaccines. A key target of these efforts is the spike (S) protein, which is …
Broad neutralization of SARS-related viruses by human monoclonal antibodies
Broadly protective vaccines against known and preemergent human coronaviruses (HCoVs)
are urgently needed. To gain a deeper understanding of cross-neutralizing antibody …
are urgently needed. To gain a deeper understanding of cross-neutralizing antibody …
Site-specific glycan analysis of the SARS-CoV-2 spike
The emergence of the betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
the causative agent of coronavirus disease 2019 (COVID-19), represents a …
the causative agent of coronavirus disease 2019 (COVID-19), represents a …
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a public health threat
for which preventive and therapeutic agents are urgently needed. Neutralizing antibodies …
for which preventive and therapeutic agents are urgently needed. Neutralizing antibodies …
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
The recurrent zoonotic spillover of coronaviruses (CoVs) into the human population
underscores the need for broadly active countermeasures. We employed a directed evolution …
underscores the need for broadly active countermeasures. We employed a directed evolution …